Collegium Pharmaceutical, Inc. Common Stock (COLL) Stock Price, Quote & AI Analysis
Live COLL stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Collegium Pharmaceutical, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Collegium Pharmaceutical, Inc. Common Stock (COLL), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Collegium Pharmaceutical, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Collegium Pharmaceutical, Inc. Common Stock Overview
Company information
Company Overview
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Collegium Pharmaceutical, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...